New HR+ HER2- mBC TROP2 ADC | Healthcare Professional Site
赞助See Data For A TROP2-Directed ADC For HR+ HER2- Unresectable Or Metastatic Breast Cancer. Visit The Site To Explore Efficacy & Safety Data For A New 2L Therapy For HR+ HER2- mBC.Service catalog: Physician Resources, Access & Support Program, Request More Info
反馈